J7131 Hypertonic Saline HCPCS Reimbursement

HCPCS Level II code J7131 denotes a 1 ml unit of hypertonic saline solution administered as an injectable or infusible medication. Nationally, accurate reporting of J7131 matters for clinical documentation, medication inventory management, and claims processing for acute and outpatient care where hypertonic saline is used for therapeutic or diagnostic purposes.

Key payers referenced in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for hypertonic saline, common sites of service where the product is provided, and the role of HCPCS coding in claims submission.

The publication provides benchmarks and reimbursement context where available, identifies common billing modifiers and payer coverage considerations, and summarizes documentation elements typically required to support medical necessity. It also outlines related administrative considerations such as unit reporting and route of administration implications. Data not available in the input is noted where specific payer policy details, taxonomies, ICD-10 mappings, and related codes would normally appear.

Billing Code Overview

HCPCS Level II code J7131 represents hypertonic saline solution, 1 ml. This code documents the provision of a concentrated saline preparation typically used for therapeutic or diagnostic purposes.

Service Type: Injectable/infusible medication administration

Typical Site of Service: Outpatient infusion centers, hospital inpatient settings, emergency departments, and other clinical settings where parenteral medications are administered.

Clinical Context

A typical patient receiving J7131 is an adult or pediatric patient with respiratory distress or thickened airway secretions requiring nebulized hypertonic saline for airway clearance. Common scenarios include patients with cystic fibrosis exacerbations, bronchiolitis, chronic bronchiectasis, or retained secretions after anesthesia. The service is administered in an acute care setting such as an emergency department, inpatient hospital ward, or pediatric/respiratory clinic with nebulization capability. Typical workflow: intake assessment by nursing or respiratory therapist, verification of orders and allergies by the clinician, preparation of the 1 ml hypertonic saline vial, delivery via nebulizer or inline ventilator circuit, monitoring for bronchospasm or desaturation during and after treatment, documentation of medication lot number and administration details, and billing using J7131 for the hypertonic saline supply plus any applicable administration CPT codes or respiratory therapy charges.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when complexity or time for administration significantly exceeds typical and payer allows.

Taxonomy Code	Specialty	Notes
`207RP1000X`	Pulmonary Disease	Pulmonologists commonly order and oversee hypertonic saline for airway clearance.
`222S00000X`	Respiratory Therapist	Respiratory therapists commonly prepare and administer nebulized hypertonic saline.
`207K00000X`	Pediatrics	Pediatricians frequently manage bronchiolitis and cystic fibrosis care involving hypertonic saline.
`208D00000X`	Critical Care Medicine	Intensivists manage nebulized therapies for ventilated patients.
`364S00000X`	Emergency Medicine	Emergency physicians frequently use nebulized agents for acute respiratory distress.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	Hypertonic saline may be used to aid sputum clearance in COPD with copious secretions.
`E84.0`	Cystic fibrosis with pulmonary manifestations	Routine use of hypertonic saline for airway clearance in cystic fibrosis care.
`J18.9`	Pneumonia, unspecified organism	Used to assist secretion clearance in patients with pneumonia who have retained secretions.
`J21.0`	Acute bronchiolitis due to respiratory syncytial virus	Nebulized hypertonic saline is commonly used in infants with viral bronchiolitis to improve mucus clearance.
`J47.9`	Bronchiectasis, unspecified	Hypertonic saline is a standard mucolytic therapy to improve expectoration in bronchiectasis.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`94640`	Pressurized or non-pressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes	Commonly used for billing the administration of nebulized hypertonic saline when performed as a respiratory therapy treatment.
`94664`	Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device	Used when patient education or technique evaluation accompanies the nebulized treatment.
`94620`	Pulmonary stress testing; spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation	May be performed before/after therapy in clinic settings to assess response when indicated.
`99070`	Supplies and materials (except spectacles), used by the physician/other qualified health care professional during the visit, provided by the office	Used to bill non-drug supplies associated with administration when allowed by payer policies.
`G0296`	Direct skilled respiratory therapy services, in the home, including assessment and training for device use and maintenance	Relevant when hypertonic saline is part of home respiratory therapy programs and billed under respiratory therapy service codes.

OpenPayer

Summary & Overview

HCPCS Level II J7131: Hypertonic Saline Solution, 1 ml